Tag: Metabolic disorders

First approved by the FDA in 2002, nitisinone has proven essential for managing rare inherited disorders. For those seeking to know **what is another name for nitisinone**, it is primarily known by its brand names, Orfadin and Nityr, and by the brand Harliku for a specific condition.

First approved by the FDA in 1995, the widely-prescribed diabetes medication metformin is a member of the biguanide drug class. This cornerstone oral therapy for type 2 diabetes is recognized for its effectiveness and long-standing use in managing blood glucose levels.

While carnitine deficiency is a more commonly discussed topic, elevated carnitine levels can also signal underlying metabolic issues. Investigating what causes elevated carnitine is crucial for diagnosing genetic disorders, effects of medication, or conditions like renal disease [1.2.1].

Over 5% of people with type 1 diabetes will experience diabetic ketoacidosis (DKA) at some point, a serious condition that causes a tell-tale fruity breath. Addressing the search query 'what drug makes you smell sweet?' requires looking beyond benign causes and understanding that this odor is often a critical warning sign of metabolic imbalance or substance misuse.

While there is no common single-drug 'leucine injection,' studies show that administering intravenous amino acid mixtures containing leucine can significantly improve protein balance and synthesis in critically ill patients requiring nutritional support.

First approved by the FDA in 1982 for treating tapeworm infections, niclosamide is an anthelmintic drug with an unexpectedly diverse range of potential therapeutic applications. Unlike many systemic drugs, its traditional use relies on its low absorption in the gastrointestinal tract, confining its action to the site of parasitic infection. However, recent research has revealed a host of other pharmacological activities, making it a prime candidate for drug repurposing.

Over 90% of patients taking corticosteroids for more than 60 days may experience adverse effects, including a number of serious conditions that worsen with steroids. Understanding these risks is crucial for anyone on a prolonged course of this powerful anti-inflammatory medication.

Benfotiamine, a lipid-soluble derivative of vitamin B1, is absorbed five times more effectively than its water-soluble counterpart. This enhanced bioavailability is key to understanding what is the drug Benfomin used for, which is most likely a reference to benfotiamine's therapeutic applications in conditions like diabetic neuropathy and thiamine deficiency.

Over the past two decades, the compound trodusquemine (MSI-1436) has been passed between multiple companies, each exploring its potential for different conditions from obesity to muscular dystrophy. The tumultuous history of who is developing trodusquemine highlights the high-stakes and often volatile nature of pharmacological research and development.